Home > > > > > Report Detail

Asthma Therapeutics - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 114
Inquire Before Buying

The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Asthma Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Asthma Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Asthma Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Asthma Therapeutics covered in this report include AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, Horizon Pharma, Mitsubishi Tanabe Pharma, Sanofi and Mundipharma, etc.

The global Asthma Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- AstraZeneca

- Boehringer Ingelheim

- F. Hoffmann-La Roche

- GSK

- Merck

- Horizon Pharma

- Mitsubishi Tanabe Pharma

- Sanofi

- Mundipharma

- Nycomed

- Kissei Pharmaceutical

- ALK-Abello

- Array BioPharma

- SAMA Pharmaceuticals

- Whanin Pharmaceutical

Global Asthma Therapeutics market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Asthma Therapeutics market, Segment by Type:

- Inhalation

- Parenteral

- Oral

Global Asthma Therapeutics market, by Application

- Hospitals

- Clinics

Core Chapters

Chapter One: Introduces the Report Scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Asthma Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

Asthma Therapeutics - Global Market Insights and Sales Trends 2024

Table of Contents
1 Market Overview of Asthma Therapeutics
1.1 Asthma Therapeutics Market Overview
1.1.1 Asthma Therapeutics Product Scope
1.1.2 Asthma Therapeutics Market Status and Outlook
1.2 Global Asthma Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Asthma Therapeutics Market Size by Region (2018-2029)
1.4 Global Asthma Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Asthma Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Asthma Therapeutics Market Size (2018-2029)
1.6.1 North America Asthma Therapeutics Market Size (2018-2029)
1.6.2 Europe Asthma Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Asthma Therapeutics Market Size (2018-2029)
1.6.4 Latin America Asthma Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Asthma Therapeutics Market Size (2018-2029)
2 Asthma Therapeutics Market by Type
2.1 Introduction
2.1.1 Inhalation
2.1.2 Parenteral
2.1.3 Oral
2.2 Global Asthma Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Asthma Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Asthma Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
3 Asthma Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Asthma Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Asthma Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Asthma Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
4 Asthma Therapeutics Competition Analysis by Players
4.1 Global Asthma Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2022)
4.3 Date of Key Players Enter into Asthma Therapeutics Market
4.4 Global Top Players Asthma Therapeutics Headquarters and Area Served
4.5 Key Players Asthma Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Asthma Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Profile
5.1.2 AstraZeneca Main Business
5.1.3 AstraZeneca Asthma Therapeutics Products, Services and Solutions
5.1.4 AstraZeneca Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 AstraZeneca Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Asthma Therapeutics Products, Services and Solutions
5.2.4 Boehringer Ingelheim Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 F. Hoffmann-La Roche
5.3.1 F. Hoffmann-La Roche Profile
5.3.2 F. Hoffmann-La Roche Main Business
5.3.3 F. Hoffmann-La Roche Asthma Therapeutics Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 GSK Recent Developments
5.4 GSK
5.4.1 GSK Profile
5.4.2 GSK Main Business
5.4.3 GSK Asthma Therapeutics Products, Services and Solutions
5.4.4 GSK Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 GSK Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Asthma Therapeutics Products, Services and Solutions
5.5.4 Merck Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Horizon Pharma
5.6.1 Horizon Pharma Profile
5.6.2 Horizon Pharma Main Business
5.6.3 Horizon Pharma Asthma Therapeutics Products, Services and Solutions
5.6.4 Horizon Pharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Horizon Pharma Recent Developments
5.7 Mitsubishi Tanabe Pharma
5.7.1 Mitsubishi Tanabe Pharma Profile
5.7.2 Mitsubishi Tanabe Pharma Main Business
5.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Products, Services and Solutions
5.7.4 Mitsubishi Tanabe Pharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Mitsubishi Tanabe Pharma Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Asthma Therapeutics Products, Services and Solutions
5.8.4 Sanofi Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Mundipharma
5.9.1 Mundipharma Profile
5.9.2 Mundipharma Main Business
5.9.3 Mundipharma Asthma Therapeutics Products, Services and Solutions
5.9.4 Mundipharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Mundipharma Recent Developments
5.10 Nycomed
5.10.1 Nycomed Profile
5.10.2 Nycomed Main Business
5.10.3 Nycomed Asthma Therapeutics Products, Services and Solutions
5.10.4 Nycomed Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Nycomed Recent Developments
5.11 Kissei Pharmaceutical
5.11.1 Kissei Pharmaceutical Profile
5.11.2 Kissei Pharmaceutical Main Business
5.11.3 Kissei Pharmaceutical Asthma Therapeutics Products, Services and Solutions
5.11.4 Kissei Pharmaceutical Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Kissei Pharmaceutical Recent Developments
5.12 ALK-Abello
5.12.1 ALK-Abello Profile
5.12.2 ALK-Abello Main Business
5.12.3 ALK-Abello Asthma Therapeutics Products, Services and Solutions
5.12.4 ALK-Abello Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 ALK-Abello Recent Developments
5.13 Array BioPharma
5.13.1 Array BioPharma Profile
5.13.2 Array BioPharma Main Business
5.13.3 Array BioPharma Asthma Therapeutics Products, Services and Solutions
5.13.4 Array BioPharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Array BioPharma Recent Developments
5.14 SAMA Pharmaceuticals
5.14.1 SAMA Pharmaceuticals Profile
5.14.2 SAMA Pharmaceuticals Main Business
5.14.3 SAMA Pharmaceuticals Asthma Therapeutics Products, Services and Solutions
5.14.4 SAMA Pharmaceuticals Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 SAMA Pharmaceuticals Recent Developments
5.15 Whanin Pharmaceutical
5.15.1 Whanin Pharmaceutical Profile
5.15.2 Whanin Pharmaceutical Main Business
5.15.3 Whanin Pharmaceutical Asthma Therapeutics Products, Services and Solutions
5.15.4 Whanin Pharmaceutical Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Whanin Pharmaceutical Recent Developments
6 North America
6.1 North America Asthma Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Asthma Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Asthma Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Asthma Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Asthma Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Asthma Therapeutics Market Dynamics
11.1 Asthma Therapeutics Industry Trends
11.2 Asthma Therapeutics Market Drivers
11.3 Asthma Therapeutics Market Challenges
11.4 Asthma Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Asthma Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Asthma Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Asthma Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Asthma Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Asthma Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Asthma Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Asthma Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Asthma Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Asthma Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Asthma Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Asthma Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Asthma Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Asthma Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Asthma Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Asthma Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Asthma Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Asthma Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Asthma Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Asthma Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Asthma Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Asthma Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Asthma Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Asthma Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Asthma Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Asthma Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Asthma Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Asthma Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Asthma Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Asthma Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Asthma Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Asthma Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Asthma Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Asthma Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Asthma Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Asthma Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Asthma Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Asthma Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Asthma Therapeutics Market
Table 40. Global Asthma Therapeutics Key Players Headquarters and Area Served
Table 41. Asthma Therapeutics Product Solution and Service
Table 42. Global Asthma Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AstraZeneca Basic Information List
Table 45. AstraZeneca Description and Business Overview
Table 46. AstraZeneca Asthma Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Asthma Therapeutics Business of AstraZeneca (2018-2023)
Table 48. AstraZeneca Recent Developments
Table 49. Boehringer Ingelheim Basic Information List
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Asthma Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Asthma Therapeutics Business of Boehringer Ingelheim (2018-2023)
Table 53. Boehringer Ingelheim Recent Developments
Table 54. F. Hoffmann-La Roche Basic Information List
Table 55. F. Hoffmann-La Roche Description and Business Overview
Table 56. F. Hoffmann-La Roche Asthma Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Asthma Therapeutics Business of F. Hoffmann-La Roche (2018-2023)
Table 58. F. Hoffmann-La Roche Recent Developments
Table 59. GSK Basic Information List
Table 60. GSK Description and Business Overview
Table 61. GSK Asthma Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Asthma Therapeutics Business of GSK (2018-2023)
Table 63. GSK Recent Developments
Table 64. Merck Basic Information List
Table 65. Merck Description and Business Overview
Table 66. Merck Asthma Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Asthma Therapeutics Business of Merck (2018-2023)
Table 68. Merck Recent Developments
Table 69. Horizon Pharma Basic Information List
Table 70. Horizon Pharma Description and Business Overview
Table 71. Horizon Pharma Asthma Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Asthma Therapeutics Business of Horizon Pharma (2018-2023)
Table 73. Horizon Pharma Recent Developments
Table 74. Mitsubishi Tanabe Pharma Basic Information List
Table 75. Mitsubishi Tanabe Pharma Description and Business Overview
Table 76. Mitsubishi Tanabe Pharma Asthma Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Asthma Therapeutics Business of Mitsubishi Tanabe Pharma (2018-2023)
Table 78. Mitsubishi Tanabe Pharma Recent Developments
Table 79. Sanofi Basic Information List
Table 80. Sanofi Description and Business Overview
Table 81. Sanofi Asthma Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Asthma Therapeutics Business of Sanofi (2018-2023)
Table 83. Sanofi Recent Developments
Table 84. Mundipharma Basic Information List
Table 85. Mundipharma Description and Business Overview
Table 86. Mundipharma Asthma Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Asthma Therapeutics Business of Mundipharma (2018-2023)
Table 88. Mundipharma Recent Developments
Table 89. Nycomed Basic Information List
Table 90. Nycomed Description and Business Overview
Table 91. Nycomed Asthma Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Asthma Therapeutics Business of Nycomed (2018-2023)
Table 93. Nycomed Recent Developments
Table 94. Kissei Pharmaceutical Basic Information List
Table 95. Kissei Pharmaceutical Description and Business Overview
Table 96. Kissei Pharmaceutical Asthma Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Asthma Therapeutics Business of Kissei Pharmaceutical (2018-2023)
Table 98. Kissei Pharmaceutical Recent Developments
Table 99. ALK-Abello Basic Information List
Table 100. ALK-Abello Description and Business Overview
Table 101. ALK-Abello Asthma Therapeutics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Asthma Therapeutics Business of ALK-Abello (2018-2023)
Table 103. ALK-Abello Recent Developments
Table 104. Array BioPharma Basic Information List
Table 105. Array BioPharma Description and Business Overview
Table 106. Array BioPharma Asthma Therapeutics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Asthma Therapeutics Business of Array BioPharma (2018-2023)
Table 108. Array BioPharma Recent Developments
Table 109. SAMA Pharmaceuticals Basic Information List
Table 110. SAMA Pharmaceuticals Description and Business Overview
Table 111. SAMA Pharmaceuticals Asthma Therapeutics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Asthma Therapeutics Business of SAMA Pharmaceuticals (2018-2023)
Table 113. SAMA Pharmaceuticals Recent Developments
Table 114. Whanin Pharmaceutical Basic Information List
Table 115. Whanin Pharmaceutical Description and Business Overview
Table 116. Whanin Pharmaceutical Asthma Therapeutics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Asthma Therapeutics Business of Whanin Pharmaceutical (2018-2023)
Table 118. Whanin Pharmaceutical Recent Developments
Table 119. North America Asthma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 120. North America Asthma Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 121. Europe Asthma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 122. Europe Asthma Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 123. Asia-Pacific Asthma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Asia-Pacific Asthma Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 125. Asia-Pacific Asthma Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 126. Asia-Pacific Asthma Therapeutics Market Share by Region (2018-2023)
Table 127. Asia-Pacific Asthma Therapeutics Market Share by Region (2024-2029)
Table 128. Latin America Asthma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 129. Latin America Asthma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 130. Latin America Asthma Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 131. Middle East & Africa Asthma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 132. Middle East & Africa Asthma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 133. Middle East & Africa Asthma Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 134. Asthma Therapeutics Market Trends
Table 135. Asthma Therapeutics Market Drivers
Table 136. Asthma Therapeutics Market Challenges
Table 137. Asthma Therapeutics Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Asthma Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Asthma Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Asthma Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Asthma Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Asthma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Asthma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Asthma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Asthma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Asthma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Inhalation
Figure 11. Global Inhalation Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Parenteral
Figure 13. Global Parenteral Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Oral
Figure 15. Global Oral Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Asthma Therapeutics Market Size Share by Type: 2022 & 2029
Figure 17. North America Asthma Therapeutics Revenue Market Share by Type (2018-2029)
Figure 18. Europe Asthma Therapeutics Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Asthma Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Asthma Therapeutics Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Asthma Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global Asthma Therapeutics Market Size Share by Application: 2022 & 2029
Figure 25. North America Asthma Therapeutics Revenue Market Share by Application (2018-2029)
Figure 26. Europe Asthma Therapeutics Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific Asthma Therapeutics Revenue Market Share by Application (2018-2029)
Figure 28. Latin America Asthma Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa Asthma Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Asthma Therapeutics Market Share in 2022
Figure 32. North America Asthma Therapeutics Market Share by Country (2018-2029)
Figure 33. U.S. Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 34. Canada Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 35. Germany Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 36. France Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. Italy Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Russia Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific Asthma Therapeutics Market Share by Region (2018-2029)
Figure 42. China Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 43. Japan Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. India Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. Australia Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America Asthma Therapeutics Market Share by Country (2018-2029)
Figure 49. Mexico Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Asthma Therapeutics Market Share by Country (2018-2029)
Figure 52. Turkey Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. UAE Asthma Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report
  • Global Montelukast Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......
  • Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......
  • Asthma Therapeutics - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114
    The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146
    Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......
  • Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144
    Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......
  • Global Doxofylline (API) Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88
    Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......
  • Global Montelukast Sodium Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs